Companies

Confo Therapeutics is a Ghent-based VIB spin-off developing GPCR-targeted drugs using proprietary conformational antibody technology, having raised EUR 60M in a Series B led by Ackermans and van Haaren in July 2024.

KiOmed Pharma is a Liege-based medtech company developing CM-chitosan injectable devices for osteoarthritis treatment, with 35,000+ patients treated and Chinese FDA approval secured.

Eyetec provides visual inspection and container closure integrity testing (CCIT) services for pharmaceutical manufacturing, along with equipment sales and after-sales support.

EyeD Pharma is a clinical-stage pharmaceutical company developing sustained-release micro-implants and complex therapeutics for ophthalmic diseases including glaucoma, dry eye, and posterior inflammation.

invoX Pharma is a research-driven biopharmaceutical company developing complex respiratory drug-device combination products using its proprietary Softhaler® soft mist inhaler platform.

Hyloris Pharmaceuticals is a company committed to addressing unmet medical needs through its product portfolio.

4Viso is an all-in-one compliance and risk intelligence platform for pharmaceutical logistics.

Bioxodes is a clinical-stage biopharmaceutical company developing Ir-CPI (BIOX-101), a first-in-class drug candidate for hemorrhagic stroke patients.

QUBES. is a biostatistics and data science consultancy supporting pharmaceutical, biotech, and medtech companies through clinical drug development from design to regulatory approval.

ANeuroTech is developing ANT01, a Phase III small molecule drug for treating Partially Responsive Depression with cognitive decline.

OLYS Pharma develops topical/transdermal treatments for chronic inflammatory pain conditions by modulating neurogenic inflammation.

Precirix is a Brussels-based clinical-stage biotech developing radiopharmaceuticals for cancer treatment, targeting solid tumors with targeted radionuclide therapy.

2Pharma Holding is a Belgian company based in Genk.